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Introduction. Starting cancer treatment early can improve outcomes. Ps hoso ial fa to s i flue i g patie ts  
medical help-seeking decisions may be particularly important in low and lower-middle income countries (LMIC) 
where cancer outcomes are poor. Comprehensive review evidence is needed to understand the psychosocial 
influences on medical help-seeking for cancer symptoms, attendance for diagnosis and starting cancer 
treatment.   
 
Methods. Mixed-methods systematic review registered on PROSPERO (CRD42018099057). Peer-review 
databases were searched until April 2020 for studies assessing patient-related barriers and facilitators to 
medical help-seeking for cancer symptoms, diagnosis and treatment in adults (18+ years) living in LMIC. Quality 
of included studies was assessed using the Critical Appraisal Skills Programme tool. Data were synthesised using 
meta-analytic techniques, meta-ethnography or narrative synthesis as appropriate.  
 
Results. Of 3963 studies identified, 64 were included. In quantitative studies, use of traditional, complementary 
and alternative medicine (TCAM) was associated with 3·60 higher odds of prolonged medical help-seeking (95% 
CI 2·06-5·14). Qualitative studies suggested that use of TCAM was a key barrier to medical help-seeking in LMIC, 
and was influenced by causal beliefs, cultural norms and a preference to avoid biomedical treatment. Women 
face particular barriers, such as needing family permission for help-seeking, and higher stigma for cancer 
treatment. Additional psychosocial barriers included: shame and stigma associated with cancer such as fear of 
social rejection (e.g. divorce/disownment); limited knowledge of cancer and associated symptoms; financial and 
access barriers associated with travel and appointments. 
 
Conclusion. Due to variable quality of studies, future evaluations would benefit from using validated measures 
and robust study designs. The use of TCAM and gender influences appear to be important barriers to help-
seeking in LMIC. Cancer awareness campaigns developed with LMIC communities need to address cultural 
















KEY QUESTIONS  
What is already known? 
 Most reviews/studies of influences on medical help-seeking for cancer have focused on high-income 
countries (HIC), and report barriers such low cancer awareness and negative beliefs about cancer. 
 Most relevant reviews that included studies only conducted in LMIC (n=3) and reviews with a global 
focus including studies conducted in both LMIC and HIC (n=4) focused on specific tumour sites and/or 
synthesised their data narratively. 
 No mixed methods systematic reviews with meta-analysis and meta-ethnography have been conducted 
to explore the patient-related psychosocial influences on medical help-seeking for cancer symptoms, 
attendance for diagnosis or the start of treatment in LMIC. 
What are the new findings? 
 We found a relatively high prevalence of use of traditional, complementary and alternative medicine 
(TCAM) which was associated with prolonged help-seeking. 
 Women faced particularly high levels of barriers, such as needing family permission to seek medical 
help, and gender-related stigma (e.g. for breast cancer treatment).  
 Our review also identified critical research design limitations reducing the utility of the literature (e.g. 
use of diffe e t ti e le gths to defi e dela  i  a e  help-seeking). 
What do the new findings imply? 
 Many studies used non-standardized measures/designs, increasing the difficulty integrating findings 
across studies. Future evaluations should use robust study designs and validated measures that have 
been translated and pilot tested. 
 Our results suggest that barriers such as low symptom knowledge and negative beliefs about cancer 
may be universal barriers to help-seeking, whereas the use of TCAM and female-specific barriers to 
medical help-seeking may be more prevalent in LMIC. 
 Our findings provide a basis for development of interventions to encourage medical help-seeking in the 




Early cancer diagnosis and treatment are key to effective and efficient treatment.[1] Cancer disproportionately 
affects low and lower-middle income countries (LMIC) with rapidly increasing incidence[2] and poorer 
survival[1] when compared to high-income countries (HIC). Earlier stage cancer at diagnosis has a significant 
impact on survival but particularly in LMIC where advanced technology critical for treatment at later cancer 
stages is generally less available.[3, 4] One factor related to access to early treatment is prompt medical help-
seeking for potential cancer symptoms.[5] Early cancer detection and treatment are seen by the World Health 
Organisation as major public health and economic issues.[6]   
 
Following the Aarhus statement,[7, 8] the cancer early diagnosis field has moved from describing the medical 
help-seeking process in terms of patie t dela , with its connotations of blame, to using time intervals as set 
out in the Model of Pathways to Treatment (MPT[9]; e.g., patient interval . The MPT describes processes 
underlying medical help-seeking for cancer symptoms and accessing treatment. The model delineates the time 
between a person first noticing a change in their body to the beginning of cancer treatment into four intervals 
(Figure 1;[9, 10]): (1) the appraisal interval (from noticing a bodily change to perceiving a reason to seek help); 
(2) the help-seeking interval (from perceiving a reason to seek help to first contact with the medical 
professional); (3) the diagnostic interval (from first contact with the healthcare professional to diagnosis of 
cancer); (4) the pre-treatment interval (from formal diagnosis to the start of cancer treatment). The patient 
interval combines both the appraisal and help-seeking intervals. In the current article we refer to longer and 
shorter intervals for the patient (medical help-seeking for cancer symptoms), diagnostic and pre-treatment 
intervals (attendance for investigations or starting treatment). Although the MPT was designed to be applicable 
globally [9], there are few examples of the model being applied to LMIC contexts.[11-13]  
<<i se t Figure 1. Model of Pathways to Treatment  he e>> 
Most research on cancer symptom appraisal and help-seeking has been conducted in HIC. In two previous 
systematic reviews of psychosocial influences on help-seeking for cancer symptoms, only 10%[14] and 15%[15] 
of studies were conducted in LMIC. Previous systematic reviews conducted in LMIC have focused on 
understanding barriers to help-seeking for breast or head and neck cancer using narrative data synthesis.[16-19] 
To date, no mixed methods systematic review has investigated patient-related influences on medical help-
seeking for cancer symptoms, attendance for examination or the start of cancer treatment in LMIC. Review of 
existing evidence regarding the psychosocial influences on cancer help-seeking in LMIC is essential, in order to 
develop effective interventions to facilitate earlier diagnosis and treatment.[1, 6]  
How patients appraise and act on potential cancer symptoms varies by tumour site and symptom type.[20, 21] 
The current systematic review therefore included all cancer types to examine the patient-related psychosocial 
influences on help-seeking for cancer during the patient interval and decisions to attend healthcare during the 
diagnostic and pre-treatment intervals in LMICs. Diverse study designs were included to identify predictors of 
help-seeking using meta-analytic techniques for the quantitative studies, and to gain an in-depth understanding 
of barriers and facilitators to help-seeking through a meta-ethnography[22] of qualitative studies. Quantitative 
data were analysed narratively to identify barriers and facilitators, including data not able to be included in the 
meta-analysis, to ensure results were comprehensive. Data were synthesised to form overarching conclusions 






This systematic review was conducted and reported in accordance with the PRISMA guidelines[23] 
(Supplementary File 1).  
Search strategy and selection criteria 
We conducted a mixed-methods systematic review of qualitative, quantitative and mixed-methods studies to 
explore patient-related barriers and facilitators to medical help-seeking behaviour for cancer symptoms and 
decisions to attend healthcare for diagnosis and start cancer treatment. The review protocol was registered with 
the International Prospective Register of Systematic Reviews (PROSPERO) prior to study selection 
(https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=99057). 
Inclusion criteria  
Studies written in English that assessed (a) patient-related (b) barriers/facilitators to medical help-seeking for 
cancer symptoms, diagnosis and the start of treatment (c) in adults (18+ years) (d) living in LMIC were included. 
LMIC was defined as low-income or lower-middle- income countries as classified by the World Bank 
(https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups), 
correct at the time of protocol development (May 2018). There were no limits on date of publication or study 
methodology. Study designs that assessed and reported observed help-seeking behaviour (retrospectively 
reported actual help-seeking behaviour in cancer patients or symptomatic participants) or hypothetical help-
seeking behaviour (anticipated help-seeking in asymptomatic community or population samples) were included.  
 
Qualitative studies that did not include time to help-seeking but where participants described their reasons for 
longer patient, diagnostic or pre-treatment intervals were included. Included studies were required to report 
the contribution of one or more of the following influences on help-seeking: symptom knowledge, symptom 
interpretation, social influences, use of traditional or alternative medicine, cancer beliefs, competing priorities, 
expectations/beliefs about care seeking, availability and access to care, financial barriers, 
understanding/navigating the health system, cultural barriers, and cancer treatment beliefs. Variables were 
selected based on our previous review[15] and extensive scoping searches. 
Exclusion criteria 
Studies that were not about cancer and/or were conducted in high-income or upper-middle-income economy 
countries were excluded. Studies that were not written in English, review papers, policy documents and 
conference abstracts were excluded, although relevant review papers were reviewed to identify studies for 
potential inclusion. Studies were excluded if they did not focus on (i) barriers to cancer help-seeking, (ii) adult 
participants  pe spe ti es, o  were (iii) low quality studies[24] as evaluated by the Critical Appraisal Skills 
Programme (CASP) tool.  
 
Search strategy 
Peer-reviewed literature in the electronic databases of Cochrane library, MEDLINE (1946-2020), Global Health 
(1910-2020) and PsychINFO (1806-2020) was searched by TD and GM up to April 2020. Initial searches were 
conducted in May 2018, and updated in June 2019 and April 2020. A comprehensive search strategy was 
developed by the study team and a subject librarian with expertise in literature searching,[24] to retrieve all 
studies relevant to the research question. Search terms relating to LMICs, symptomatic help-seeking, decisions 
to initiate treatment, cancer, and barriers to help-seeking were used to search for relevant studies 





Titles and abstracts of studies were reviewed against the inclusion and exclusion criteria by TD and GM. Full 
texts of included studies were reviewed for inclusion or exclusion by TD and GM (Figure 2). Reference lists of 
included studies were checked manually by GM for additional studies. Ten percent of studies at each stage were 
independently reviewed for inclusion by GM, HSQ and KB, with good agreement (93%). All discrepancies were 
resolved through discussion. 
 
Data analysis 
Data were analysed using a parallel-results convergent design,[25] where qualitative and quantitative findings 
were analysed separately and integrated in the discussion.  
 
Data extraction 
Data from all included studies were extracted onto an Excel sheet (Supplementary File 3 for full list of extracted 




The CASP(www.casp-uk.net) tools were used to assess quality of studies in the following domains: validity of 
results, research design, participant recruitment, data collection, ethical issues, data analysis and reporting, and 
consideration of the contribution of their research. The tools were adapted to include questions to assess the 
quality of the patient interval.[7, 8] When assessing the quality of the reported patient interval the following 
were considered: the length of time from cancer diagnosis to data collection; whether self-report patient 
interval data were triangulated with medical records; how the patient/diagnosis/pre-treatment interval was 
classified, and how the patient interval was analysed.[7, 8] Quality was rated as low, medium or high. Low 
quality studies were excluded. The main reasons for exclusion included insufficient information provided about 
data collection procedures (n=18), or where intervals were measured but not reported or defined (n=7). 
 
Quantitative Summarisation 
All included quantitative studies were discussed in detail during team meetings (BW, GM, DA, YD, HH). Due to 
the high level of heterogeneity in study measures and research designs within the context of relatively few 
studies, a formal meta-analysis was not feasible for most variables. However, meta-analytic techniques were 
used to quantitatively summarise study results regarding use of traditional, complementary and alternative 
medicine (TCAM) (e.g. traditional healers, herbal medication, prayer camps, spiritual healers) as a predictor of 
help-seeking in the patient interval because TCAM use was consistently reported between studies and a high 
proportion of quantitative studies reported TCAM use. We first summarised the proportion of research 
participants who used TCAM in the patient interval, weighting studies by the square root of their sample size 
(proportional to the inverse of the sta da d e o  fo  that sa ple s pa a ete  esti ate). We then assessed the 
proportion of participants who experienced significantly longer patient intervals, defined as a patient interval of 
three months or longer. Third we summarized within-study statistics of relations between TCAM use and the 
probability of a longer patient interval. We extracted from the report (or computed if not reported) the odds 
atio fo  the effe t of TCAM o  dela , al ulated as the odds of having a longer patient interval if a participant 
had used TCAM, over the odds of having a longer patient interval given a participant had not used TCAM. The 
ea  odds atio, eighted  the s ua e oot of ea h stud s sa ple size, as o puted. Sub-group analyses 
were conducted for TCAM use as a function of the region in which the studies were conducted (Africa vs. Asia), 





Qualitative data from all qualitative and mixed-methods studies were s thesised usi g No lit a d Ha e s 
(1988)[22] seven-stage meta-ethnographic approach (Table 1). Meta-ethnography reporting guidance 
(eMERGe)[27] was used. 
 
Table 1.  Noblit and Hare’s 1  seven-stage meta-ethnographic approach 
 
Stage in Noblit and Hare 
(1988)26  
Activity 
1. Development of the 
research question 
Align with the overarching research question of the review: What a e the 
patient-reported influences on medical help seeking in the patient, 
diagnostic and pre-treatment intervals i  LMICs?   
2. Scope of synthesis Define scope of the meta-ethnography to align with the overarching scope 
of the review: (i) focus on medium and high quality studies; (ii) focus on 
data related to patient reported influences on medical help seeking in the 
patient, diagnostic and pre-treatment intervals; (iii) do not include data 
from proxies (e.g. spouses, children healthcare professionals) due to the 
focus on patient reported influences 
3. Develop main concepts Familiarisation with studies. Develop main concept grid with main and sub-
concepts and description. Refine main concept grid 
4. Determine how studies 
are related 
Extract and separate first order data (participant quotes) and second order 
data autho s  a ati e i te p etatio s  from included studies into NVivo 
(GM). Code data under each of the main concepts (GM). Dual code at least 
20% of included studies (HSQ and KB). Discuss and resolve discrepancies in 
coding (GM, KB, HSQ)  
5. Translate studies Create a matrix on Excel to summarise study characteristics, first and 
second order data under each of the main- and sub-concepts (GM) 
6. Synthesise translations Three researchers (GM, KB, HQS) to independently review the main 
concept matrix of included first and second order data to generate an 
overarching summary of each main concept (third order data). Workshop-
style analysis meeting to discuss how studies relate, and to identify areas 
of accordance and discordance. Discuss overall interpretations and 
conclusions and how main concepts relate with one another 
7. Dissemination Express the synthesis through dissemination 
 
Patient and public involvement 









Of the 3511 studies screened for inclusion in the review, 64 met the inclusion criteria (Figure 2).  
<<Insert Figu e . P‘I“MA flo  ha t of stud  sele tio  he e>> 
As shown in Table 2, data were collected using quantitative survey methods (n=38), qualitative interviews or 
focus groups (n=24) and mixed-methods (n=2) to assess observed (n=46), hypothetical (n=16) and both 
observed and hypothetical (n=2) help-seeking behaviour.   
Thirty-five studies were conducted in Sub-Saharan Africa (Uganda, n=7; Nigeria, n=6; Ghana, n=5; Ethiopia, n=4; 
Kenya, n=3; Mali, n=2; multiple countries, n=2; Cameroon, n=2; Rwanda, n=1; Burkina Farso, n=1; Malawi, n=1; 
Sudan, n=1).  Fourteen studies were conducted in South Asia (India, n=6; Pakistan, n=5; Bangladesh, n=2; Nepal, 
n=1). Ten studies were conducted in the Middle East and North Africa (Jordan, n=5; Egypt, n=4; Morocco, n=1). 
Four studies were conducted in East Asia and Pacific (Indonesia, n=4). One study was conducted in Latin America 
and Caribbean (Haiti, n=1).   
Most studies focused on breast cancer (n=44). The remaining 20 studies focused on the following cancer sites: 
colorectal (n=3), multiple sites (n=6), cervical (n=4), oral (n=2), ovarian (n=1), prostate (n=1), lung (n=1), 
nasopharyngeal carcinoma (n=1), and Kaposi carcinoma (n=1). Studies focused on the patient interval (n=54), 
diagnostic interval (n=10) and pre-treatment interval (n=21).  












Table 2. Characteristics of included studies  










189 participants: men (n=87); women (n=91). Mean age: 57·5 years. 
Marital status: married (n=152); single (n=4); widow/divorced (n=22). 
Education: illiterate (n=30), primary school (n=48), secondary school 
(n=61), college (n=15), university (n=25). Employment: employed full time 
(n=22), employed part time (n=8), housewife (n=62), retired (n=48), 
unemployed (n=40). Income (family): <399 JD (n=113); >400 JD (n=63). 
















Agbokey et al 
(2019)[29] 
20 women. Median age: 52·5 years (range: 29-80 years). Marital status: 
married (n=18); widowed (n=2). Education: no formal education (n=4); 
basic (n=12); secondary (n=1); tertiary (n=3). Employment: farming (n=5); 






Ghana (LM) Breast N/A PI (3 
months; ··) 
High  
Ahmad et al 
(2017)[30] 
100 women. Mean age: 41 years (range: 18-67 years). Marital status: 
married (n=76); not married (n=23). Education: less than grade 10 (n=17); 
grade 10/university/college (n=31); post-grad education (n=52). 
Employment: employed (n=66); not employed (n=34). Income (annual 
household): below average (n=26); above average (n=74) 
Hypothetical; 
Vignette survey 








survey of a 










Al Qadire et 
al 
(2017a)[31] 
241 participants: male (n=106); female (n=135). Mean age: 27·9 years 
(range: 18-47). Marital status: married (n=125); not married (n=116). 
Education: secondary or lower (n=177); diploma or more (n=31). 
Employment: working (n=40); not working (n=201). Income (monthly 
family): low (<845 US$; n=210); high (>845 US$; n=31). 
Hypothetical; 
Cross-sectional 
survey with Syrian 
refugees living in 
Jordan  
Jordan (UM) All 
cancers 
Adapted 




PI (2 weeks; 
24·9%) 
Medium  
Al Qadire et 
al 
(2017b)[32] 
2292 participants: male (n=1206); female (n=1073); missing (n=13). Mean 
age: 30·5 years (range: 18-81). Marital status: married (n=1108); not 
married (n=1169); missing (n=15). Employment: working (n=1013); not 
working (n=1247); missing (n=32). Income (monthly family): low (<845 





Jordan (UM) All 
cancers 
Adapted 










30 women; Age range: 25-67 years (60% aged 40+ years). Education: 
illiterate/never been to school (n=2); primary education (n=7); secondary 





Stage II and III 









12 women. Age range: 31-60 years. Marital status: married (n=9); 





late stage breast 
cancer patients 
Ghana (LM) Breast  N/A TI (··) Medium 
Basharat et al 
(2019)[35] 





Pakistan (LM) Oral  N/A PI (1 month; 
100%) 
Medium 
Bonsuid et al 
(2019)[36] 
11 women. Age range: 32-70+ years. Marital status: married (n=5); 
divorced (n=3); single (n=2); widowed (n=1). Employment: unemployed 
(n=3); trader (n=5); self-employed (n=2); retired teacher (n=1). Education: 












De Boer et al 
(2014)[37] 
161 participants: male (n=111); female (n=50). Mean age: 34 years. 
























Deliana et al 
(2019)[38] 
15 participants: male (n=2); female (n=13). Age categories: 17-35 years 
(n=1); 36-45 years (n=5); 46-55 years (n=6); 56-65 years (n=2); 65+ years 







(Stages III and IV) 










N/A TI (··) Medium 
11 
 
Dereje et al 
(2020)[39] 
231 women. Mean age: 52·6 years (range: 23-86 years). Martial status: 
married (n=96); single (n=11); divorced (n=36); widowed (n=88). 
Education: unable to read or write (n=89); primary (n=85); secondary 
(n=42); diploma (n=15). Employment: housewife (n=144); government 
employed (n=29); privately employed (n=23); merchant (n=10); daily 
laborer (n=13); pensioner (n=8); other (n=4). Income (family): <3201 






68 days of the 
study) 









Desalu et al 
(2016)[40] 
1125 participants: male (n=578), female (n=546). Mean age: 33 years (SD: 
10 years). Marital status: married (n=647); not married (n=478). 
Education: none/ primary (n=293); secondary (n=364); tertiary (n=468). 
Income: low (n=883); middle-high (n=242). Smoking status: current 






Nigeria (LM) Lung Lung Cancer 
Awareness 
Measure 
PI (2 weeks; 
33·2%) 
High 
Dye et al 
(2012)[41] 
 







Ethiopia (L) Breast N/A PI ig o ed 













6 months of the 
study). 





PI (1 month; 
53%)  
Medium  
Fles et al 
(2017)[43] 
 
12 participants: male (n=8); female (n=4). Mean age: 44 years. Marital 
status: married (n=9); not married (n=2); widowed (n=1). Education: 
completed primary school or below (n=6); completed high school or above 
(n=6). Employment: housewife (n=3); employed (n=8); student (n=1) 














N/A PI (median 
PI = 5·5 
months) 
Medium  
Foerster et al 
(2019)[44] 
1325 women. Mean age: 50·7 years (SD: 13·6 years). Employment: Skilled 
(n=403); unskilled/not applicable (n=923). Socioeconomic group: low 























Frie et al 
(2018)[11] 
 
25 women (demographics reported by focus group). Group 1 (breast 
cancer survivors, n=8): Mean age: 48 years (range: 35-61 years). Marital 
status: married (n=8). Education: most had secondary education (numbers 
··). Group 2 (community members, n=12): Mean age: 42 years (range: 20-
65 years). Marital status: married (n=12). Education: none (n=6); 
primary/secondary (n=6). Group 3 (community members, n=5): Mean age: 
41 years (range: 22-45 years). Marital status: married (n=4); single (n=1). 




groups: one with 
breast cancer 
survivors and two 
community 
members 
Mali (L) Breast  N/A PI (··); DI 
(··); TI (··) 
Medium 
Frie et al 
(2018)[45] 
64 women. Marital status: married (n=45); not married (n=19). 
Employment: housewife (n=34); working (n=30). Size of tumour: T0/T1/T2 





























Freij et al 
(2018)[46] 
896 women. Mean age: 41 years (range: 18-85 years). Marital status: 
single (n=181); married (n=618); divorced/ widowed (n=89); not given 
(n=8). Education: Secondary school and below (n=399); diploma and above 
(n=497). Employment: full time (n=705); not working or retired (n=191). 




women with no 
previous 
diagnosis of 
ovarian cancer  




PI (2 weeks; 
20·8%) 
High 
Gadgil et al 
(2015)[47] 
389 women. Mean age: 48 years (range: 30-69 years). Income: high 
(n=147); middle (n=140); low (n=82) 
Hypothetical; 
Cross-sectional 
postal survey with 
middle class 
urban women 
living in Mumbai 














Gakunga et al 
(2019)[48] 
6-11 women in each group. Age range: 30-60 years. Socioeconomic status: 
Group 1 (breast cancer diagnosis; high SES); Group 2 (breast cancer 
diagnosis; low SES); Group 3 (no breast cancer diagnosis; high SES); Group 













cancer and two 
groups with 








441 women. Mean age: 44.4 years (SD: 12·2 years). Marital status: 
married (n=255); widowed (n=73); single (n=67); divorced (n=46). 
Education: not attended school (n=87); primary school (n=112); secondary 
school (n=142); diploma and above (n=100). Employment: housewife 
(n=217); employed outside the home (n=198); retired (n=13); not 
employed (n=13). Income (family monthly): <194 US$ (n=325); >194 US$ 










PI (90 days; 





12 women . Age range: 26-65 years. Marital status: married (n=9); 
widowed (n=3). Education: Illiterate (n=5); primary (n=3); secondary (n=1); 
diploma and above (n=3). Employment:  housewife (n=2); farmer (n=6); 
merchant (n=1); government employee (n=3). Area of residence: urban 










685 women. Mean age: 49 years (range: 16-84). Marital status: married 
(n=530); not married (n=155). Education: no education (n=253); 
primary/middle education (n=130); high school (n=50); graduate (n=252). 









urban and rural 








the UK  







50 women. Age range: 34-65 years. Marital status: married (n=44); 
widowed (n=6). Education: none (n=3); elementary school (n=23); junior 
high school (n=13); senior high school (n=11). Employment: 
housewife/unemployed (n=42); laborer/irregular job (n=7); private 
employee (n=1). Stage of disease: stage I (n=0); Stage II (n=18), Stage III 







Indonesia (LM) Breast  N/A PI (3 
months; 









70 women. Mean age: 45·6 years (range: 28-66). Marital status: married 
(n=57); widowed (n=11); single (n=2). Education: none (n=7); elementary 
school (n=36); junior high school (n=11); senior high school (n=10); college 
or university (n=6). Employment: housewife/unemployed (n=46); 
laborer/regular job (n=18); private employee (n=1); government officer 
(n=5). Income (family): <$200 (n=53); $200-$300 (n=13); >$300 (n=4). 
Health insurance: yes (n=14); no (n=56). Stage of disease: I (n=3); II (n=37); 






































25 men. Mean age: 59·3 years. Marital status: married (n=20); single 
(n=5). Education: less than high school (n=15); high school (n=4); 
university (n=6). Employment: employed (n=12); retried (n=10); 
unemployed (n=3). Income: low (n=15); middle (n=6); high (n=2); missing 
(n=2).  
Hypothetical; 
Focus groups with 
a community 
sample of men 
with no previous 
diagnosis of 
prostate cancer 
Cameroon (LM) Prostate N/A PI (··) Medium 
Khan et al 
(2015)[55] 
315 women. Age: <40 years (n=54); >40 years (n=111). Marital status: 
married (n=294); not married (n=21). Education: under 8 years (n=234); 














Khaliq et al 
(2019)[56] 
200 women. Marital status: married (n=169); not married (n=31). Median 
age: 45 years (range: 22-70). Education: median 2 years (range 0-16 
years). Employment: self-employed (n=19); employed (n=35); housewife 
(n=146). Income (monthly; PKR): median 15,250 (range: 0-150,000). Area 

















care = 89 
days) 
Medium 
Kishore et al 
(2007)[57] 
95 participants: equal numbers of males and females (actual numbers ··). 
















cancer (within 1 
month) 
Kohler et al 
(2017)[58] 
 
20 women. Median age: 47 years). Age group: 25-40 (n=9); 41-55 (n=4); 
56+ (n=7). Marital status: married (n=15); single/divorced (n=2); widowed 
(n=3). Education: no formal schooling (n=5); some primary schooling 












Kumar et al 
(2019)[59] 
Quantitative component: 269 women. Age group: 25-44 (n=90); 45-64 
(n=162); 65+ (n=17). Marital status: married (n=235); unmarried (n=16); 
widowed (n=18). Education: no formal education (n=70); primary (n=34); 
middle (n=43); secondary (n=58); higher secondary (n=36); graduate and 
above (n=26%); missing (n=1). Employment: home maker (n=230); daily 
wage (n=5); farmer (n=1); salaried (n=16); business (n=5); other (n=9); 
missing (n=3). Area of residence: urban (n=73); rural (n=195); missing 
(n=1). Socioeconomic status: lower class (n=74; middle class (n=67); upper 











patients with a 
patient interval of 
3 months or 
longer 











137 women. Mean age: 48·3 years. Marital status: married (n=77); single 
(n=26); widowed/divorced (n=34). Education: illiterate (n=115); primary 
(n=14); secondary/higher (n=8). Employment: no employment (n=23); 
housewife (n=102); full time employed (n=10); part time employed (n=2). 






with a PI of 3 
months or longer 




PI (median = 
6 months); 
DI (median 
= 1 month) 
High 
Leng et al 
(2020)[61] 
186 participants: male (n=58); female (n=127). Median age: 50 years 
(range: 19-79 years). Marital status: married (n=162); divorced/separated 
(n=2); widowed (n=12); never married (n=10). Education: none (n=20); 
primary (n=46); secondary (n=52); vocational/technical (n=18); 
pol te h i /OND/so e ollege = ; Bat helo s deg ee = ; 
postgraduate degree (n=9). Employment: none (n=37); trader (n=68); 



















138 women. Mean age: 46 years. Marital status: married (n=132); single 
(n=4); divorced/widowed (n=2). Education: illiterate (n=43); high school 
(n=61); college or above (n=33). Employment: homemaker (n=125); 
















presenting with a 
lump 
Manir et al 
(2017)[63] 
212 women. Median age: 24 years (range 21-54 years). Education: 
postgraduate (n=129); undergraduate (n=83) 
Hypothetical; 
Cross sectional 










PI (1 month; 
48·6%) 
Medium  
Martei et al 
(2011)[64] 
 









Ghana (L) Breast  N/A PI (··) Medium 
McEwan et al 
(2014)[65] 








Egypt (LM) Breast N/A PI (3 
months; 
60%); DI (3 
months; 






20 women. Age range: 35-67 years. Age group: 30-39 (n=1); 40-49 (n=8); 
50-59 (n=6); 60-69 (n=5). Marital status: married (n=11); 
separated/divorced (n=2); widowed (n=4); single (n=3). Education: primary 







as being in 
remission for 1+ 
years) 
Uganda (L) Breast N/A TI (··) Medium  
Mhaidat et al 
(2018)[67] 
801 participants: male (n=568); female (n=233). Marital status: married 
(n=29); single (n=772). Mean age: 20.36 years (range: 18-37 years). Age 
group: <20 years (n=295); >20 years (n=506). Education: medical related 






students from five 
universities  
Jordan (UM) Colorectal Adapted 












6-7 participants in each of eight focus groups (exact numbers ··). Age 
range: 20-60 years  
Hypothetical; 
Eight focus groups 
(two in a middle 
income urban 
area; two in a low 
income urban 









Kenya (L) Breast N/A PI (··) Medium 
Mwaka et al 
(2016)[12] 
149 women. Mean age: 48 years. Age group: 18-29 (n=7); 30-44 (n=52); 
45-59 (n=63); 60+ (n=25); missing (n=2). Education: no formal education 
(n=67); primary (n=72); secondary (n=7); tertiary (n=2); missing (n=1). 
Employment: housewife/peasant (n=132); petty trader (n=10); formally 
employed (n=4); missing (n=3). Stage: I (n=17); II (n=29); III (n=67); IV 

















Mwaka et al 
(2015a)[69] 
 
Total number of participants ··. Age range: 18-59   Hypothetical. 
Twenty-four focus 
groups with 
members of the 
community living 
in rural (12 focus 
groups) or urban 
areas (12 focus 
groups)  
Uganda (L) Cervical N/A  TI (··) High 
Mwaka et al 
(2015b)[13] 
18 women. Mean age: 42 years (range= 35-56). Employment: subsistence 
farmers (n=15); small scale businesses workers (n=2); formally employed 















136 women. Country: Sierra Leone (n=57); Rwanda (n=79). Median age: 
Sierra Leone (31 years); Rwanda (43 years). Education: none (n=71); 




Sierra Leone (L) 










Employment: none (n=19); home maker (n=7); domestic helper (n=2); 
farmer (n=96); self-employed/small business (n=12) 
reported current 
breast masses in 
women and help 
seeking/barriers 
to help seeking in 
those reporting a 







Odongo et al 
(2015)[71] 
162 women. Mean age: 45 years. Marital status: married (n=87); single 
(n=20); widowed (n=25); divorced (n=28). Education: none (n=15); primary 
(n=54); secondary (n=57); tertiary (n=36). Employment: unskilled worker 
(n=36); subsistence farmer (n=53); formal employment (n=29); 
unemployed (n=44). Income (monthly): <93,750 shillings ($36USD; n=70); 
>93,750 shillings ($36USD; n=91). Area of residence: rural (n=142); urban 













Okobia et al 
(2006)[72]  
1000 women. Mean age: 29 years (range 15-91). Marital status: married 
(n=484); single (n=451); divorced/separated (n=21); widowed (n=23); 
missing (n=21). Education: primary (n=222); secondary (n=442); 




women living in 
an urban 
community 












275 women. Age group: 25-35 (n=30); 36-46 (n=102); 47-57 (n=66); 58-68 
(n=49); 69-79 (n=28). Marital status: single (n=12); married (n=193); 
divorced/separated (n=19); widowed (n=51). Education: primary (n=46); 
secondary (n=87); tertiary (n=142). Employment: unemployed (n=124); 
employed (n=151). Income: <18,000 (below national minimum wage; 


















Pace et al 
(2015)[74] 
144 women. Median age: 49 years. Marital status: married (n=71); 
single/widowed/divorced (n=73). Education: none/primary (n=108); 















Price et al 
(2012)[75] 

























40%); TI (1 
week; 16%) 
Medium 
Pruitt et al 
(2015)[76] 
31 women. Mean age: 51 years (range: 28-over 80). Education: no formal 











Salih et al 
(2016)[77] 
63 women. Mean age: 46.89 (range: 22-91). Marital status: married (n=7); 
single (n=56). Education: illiterate (n=22); literate (n=41). Employment: 
unemployed (n=53); employed (n=10). Income (annual): <GDP per Capita 




















Sanuade et al 
(2018)[78] 
20 women. Age groups: <40 years (n=2); 40-49 years (n=8); 50-59 years 
(n=6); 60+ years (n=4). Marital status: married (n=16); widowed (n=2); 
separated (n=2). Education: none (n=2); primary (n=2); middle (n=4); 
secondary (n=4); tertiary (n=4); missing (n=4). Employment: unemployed 
(n=2); trader (n=11); other (n=7). Stage: I and II (n=13); III and IV (n=7) 
Observed; Four 
focus groups with 
breast cancer 
patients 
Ghana (LM) Breast  N/A TI (1 month; 
78·9%) 
Medium  
Sayed et al 
(2019)[79] 
697 survey participants. Female participants (n=442): Median age: 22 
years (range: 19-25 years). Marital status: married (n=307); single (n=70); 
widowed (n=40); divorced (n=17). Education: none (n=212); primary 
(n=182); secondary (n=30); tertiary (n=8); adult education (n=5). 
Employment: farmer (n=-136); trader (n=47); housewife (n=77); other 
(n=76); none (n=102). Male participants (n=237): Median age: 31 years 
(range: 24-43 years). Marital status: married (n=173); single (n=49); 
widowed (n=8); divorced (n=5). Education: none (n=48); primary (n=133); 
secondary (n=44); tertiary (n=9); adult education (n=2). Employment: 
farmer (n=90); trader (n=36); other (n=80); none (n=30) 
Hypothetical; 
Mixed-methods 
study involving a 
cross-sectional 




and six focus 
groups with a 
community 
sample 




PI (1 week; 
9·3%) 
Medium  
Sharma et al 
(2013)[80] 
90 women. Mean age: short PI groups (45 years); long PI group (49 years). 
Marital status: married (n=36); not married (n=35); missing (n=19). 
Education: none (n=16); primary (n=32); secondary (n=22); university 
(n=6); missing (n=14). Employment: unemployed (n=58); employed (n=29); 














Sharp et al 
(2019)[81] 
341 women. Age group: 25-39 (n=182); 40-49 (n=89); 50-74 (n=70). 
Marital status: married/living with significant partner (n=207); single 
(n=129). Education: primary (n=236); above primary (n=104). Employment: 
full-time employed/student (n=235); not in full-time employment/not full-
time student (n=99); missing (n=7). Income: <500,000 shillings (n=125); 





sample of women 
without breast 
cancer 

















343 women. Mean age: 49 (range 22-81). Stage: I and II (n=185); III and IV 
(n=158). Education: no formal schooling (n=201); completed primary 
school (n=63); completed secondary school (n=78). Employment: 















Steiness et al 
(2018)[83] 
43 women. Mean age: 34·7 years (range: 18-60). Marital status: married 
(n=34); separated (n=4); divorced (n=1); widowed (n=3); never married 
(n=1). Education: none (n=10); primary (n=8); secondary (n=19); college+ 
(n=6). Perceived wealth in comparison to neighbours: ette  tha  








symptoms (but no 
formal diagnosis 
of cancer) 
Bangladesh (L) Breast  N/A PI  Medium 
Strobele et al 
(2018)[84] 
996 women. Mean age: 33·4 years (range: 18-86). Marital status: married 
(n=795); not married (n=201). Education: none (n=557); elementary 
(n=192), secondary (n=134); tertiary (n=57, 5.7%); university (n=55); 
missing (n=7). Employment: housewife (n=167); farmer (n=369); business 





survey to assess 
current or former 
breast symptoms 
in women, help 
seeking in those 
reporting 
symptoms and 
















Tessler et al 
(2015)[85] 
1942 participants (18+; age and gender of sample ··). Of the thirty-eight 





survey to assess 
current or former 
rectal bleeding in 
the population, 
help seeking in 
those reporting 
symptoms and 
barriers to help 
seeking 














Uddin et al 
(2012)[86] 
48 women. Marital status: married (n=43); not married (n=5). Mean age: 
37·5 years (range: 20-69). Education: illiterate (n=9); less than high school 
(n=7); high school (n=17); Bachelors (n=14); graduate degree (n=1). 




in urban (n=2) 
and rural (n=4) 
communities   
 
Egypt (LM) Breast N/A PI  Medium  
Ukwenya et 
al (2008)[87] 
111 women. Median age (split by g oup : sho t i te al   ea s ; lo g 
i te al   ea s . Marital status: married (n=97); not married (n=14). 
Education: illiterate/primary (n=59); secondary/tertiary (n=52). Stage: I 















Zahid et al 
(2014)[88] 
190 participants: men (n=119); women (n=71). Mean age: 48·3 years. 
Marital status: married (n=136); not married (n=54). Education: <Grade 5 
(n=161); Grade 5-10 (n=19); >Grade 10 (n=10). Income (monthly): 




survey with oral 
cancer patients 




TI (mean = 
6·3 days) 
Medium  
$Country classification in final year of data collection as defined by the World bank 
(https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups) L=low-income 
economy; LM= low-middle income economy; UM=upper-middle income economy.  
*PI refers to patient interval; DI refers to diagnostic interval; TI refers to pre-treatment interval. The number of days/weeks in brackets denotes 
the cut off for a long vs short interval and the % of participants with a long interval. Mean/median/binary interval times are given in some studies.  













Traditional, complementary or alternative medicine (TCAM). Frequency of TCAM use in the patient interval was 
reported in 11 studies (n=2,415 participants; 10 breast cancer studies, one non-breast cancer study), and the 
mean proportion of TCAM use across the studies was 0·20 (95% CI 0·09-0·31).[37, 47, 51, 53, 62, 70, 71, 74, 75, 
79, 87] The mean proportion of TCAM use in the patient interval in African studies (n=7) was 0·23 (95% CI 0·07-
0·40), and 0·17 (95% CI -0·08-0·42) in Asian studies (n=4).  Five studies (n=953 participants; four African studies, 
one Asian study) assessed the association between TCAM use and a longer patient interval, with a mean odds 
ratio of 3·60 (95% CI 2·06-5·14).[37, 39, 62, 71, 74] The mean odds ratio was 4·32 (95% CI  1·54-7·11) for breast 
cancer studies (n=3) and 2·58 (95% CI 1·39-3·77) for non-breast cancer studies (n=2). Nine studies (eight African 
studies, one Asian study) assessed the proportion of participants who used TCAM who also had patient intervals 
greater than three months, with the mean proportion equal to 0·45 (95% CI 0·29 to 0·61).[28, 37, 39, 49, 71, 73, 
75, 77, 80] The proportion of participants who used TCAM who had patient intervals longer than three months 
was 0·51 (95% CI 0·27-0·76) in breast cancer studies (n=6) and 0·33 (95% CI 0·06-0·60) in non-breast cancer 
studies (n=3). 
Gender roles. In five female-only observed studies with breast cancer patients, competing priorities such as 
housework or childcare were reported as a barrier in the patient interval in Pakistan[62] and in African countries 
[49, 60, 73, 74] (Table 3). In three breast cancer studies women reported embarrassment about the medical 
examination  as an actual[60] or anticipated[63, 81] barrier to help-seeking in the patient interval in India[63] 
and in African countries[60, 81] (Table 3).  
 
Cancer knowledge. Lower cancer symptom knowledge was associated with longer anticipated patient intervals 
in three hypothetical studies with various cancers in Jordan[31, 32] and lung cancer in Nigeria[40], while one 
hypothetical study found no association between ovarian cancer symptom knowledge and anticipated time to 
help-seeking in Jordan.[46] In hypothetical studies, good lung cancer symptom knowledge was associated with 
higher educational attainment and higher income in Nigeria,[40] while good ovarian cancer symptom knowledge 
was associated with higher income, but not educational attainment in Jordan.[46] Living in an urban area in 
India was associated with good breast cancer symptom knowledge in one hypothetical study.[51] 
 
Misattribution of symptoms[12, 28, 45, 60, 62, 71, 80] was associated with a longer patient interval in seven 
observed studies with breast,[45, 60, 80, 87] colorectal,[28] cervical[39] and oral[88] cancer patients (Table 3). 
Absence of pain was reported as a barrier to help-seeking in the patient interval in four observed studies with 
breast cancer[55, 60, 82] or Kaposi s sarcoma[37] patients (Table 3).  
Emotional barriers to help-seeking. Fear of cancer was a barrier to help-seeking in the patient interval in five 
observed studies with breast[62, 73, 74, 80] and oral cancer patients[88] in African, Asian and Caribbean 
countries (Table 3). Fear of breast cancer surgery was not associated with longer patient intervals in one 
observed study conducted in Uganda.[71] Concerns about escalation of their cancer and a negative impact on 
relationships led to refusal of treatment in two observed studies with breast cancer patients conducted in 
African countries.[44, 87]   
Access barriers. In four observed studies, long travel times to hospital were reported in African countries[61, 74, 
75] and in Indonesia[53](Table 3). In two hypothetical studies conducted in Jordan, participants anticipated 
difficulty in arranging transport as a possible barrier in the patient interval[31, 32] (Table 3).  
Financial barriers. In three hypothetical studies[31, 32, 81] and 15 observed studies with breast[49, 55, 60, 70, 
73, 74, 77, 80] and non-breast[12, 37, 39, 61, 75, 85, 88] cancer patients conducted in African, Asian and 
Caribbean countries, participants cited financial barriers as major contributors to longer patient intervals or not 
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seeking medical help for symptoms,[70, 85] (Table 3). In two observed studies conducted in African countries, 
breast cancer patients refused[44] or postponed treatment[75] due to financial issues (Table 3). Participants in 
observed studies conducted in African countries reported having to rely on gift/loans from friends and family 
during the pre-treatment interval to fund treatment for various cancers [61, 75] (Table 3).    
Cancer beliefs. Three hypothetical studies conducted in India[47] and in African countries[72, 79] reported 
awareness of the benefits of early breast cancer diagnosis. One hypothetical breast cancer study conducted in 
Kenya[79] and one observed study conducted in India with various cancers[57] reported beliefs that cancer was 
incurable (Table 3). Negative breast cancer beliefs were more prevalent in women living in urban areas in 
Morocco in one observed study;[60] conversely, one hypothetical study reported higher negative beliefs about 
breast cancer among women living in rural areas in India.[51] Participants in an observed study in India with 
various cancers believed that cancer was caused by evil spirits and could be cured by rituals and 
worshipping.[57] In one hypothetical study conducted in Nigeria, women believed that breast cancer was caused 
by evil spirits.[72] In an observed study of multiple cancers conducted in India, over half of the sample thought 
that cancer was contagious or were unsure, with those from lower socioeconomic groups more likely to believe 
that cancer was contagious.[57] 
Social influences. In two observed studies conducted in Pakistan with oral[88]and breast [56] cancer patients, 
encouragement to seek medical-help from their social network promoted help-seeking in the patient 
interval[56, 88] and attendance for diagnostic appointments in the diagnostic interval.[56] However, one 
observed study conducted in Pakistan found that breast cancer patients who disclosed symptoms to their social 
network experienced longer patient intervals.[62] One observed study conducted in Uganda found that breast 
cancer patients with no social support experienced longer patient intervals.[71] 
 
Table 3. Summary of narrative synthesis for quantitative studies  
Measure % of participants endorsed 
– observed studies 
% of participants endorsed 
– hypothetical studies 
Patient interval   
Cancer knowledge   
Initially unaware their symptoms could indicate 
cancer 
23%[62]; 40%[12]; 47%[80]; 
59%[28]; 66%[60]; 69%[71]; 
78%[45]  
·· 
Absence of pain  4%[82]; 17%[55]; 42%[60]; 
48%[37] 
·· 
Emotional barriers to help seeking   
Fear of cancer 6%[62]; 6%[74]; 11%[80]; 
38%[88]; 71%[73]  
·· 
Access barriers   
Anticipated difficulty in arranging transport ·· 29%[32]; 49%[31]  
Financial barriers   
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Anticipated medical costs ·· 42%[31]; 68%[81]; 83%[32] 
Financial barriers 2%[49]; 3%[85]; 6%[39]; 
7%[60]; 14%[74]; 17%[77]; 
21%[80]; 24%[61]; 25%[55]; 
25%[12]; 32%[37]; 35%[70]; 
75%[75]; 75%[88]; 76%[73] 
·· 
Cancer beliefs   
Aware of the benefits of early breast cancer 
diagnosis 
77%[88]  41%[72]; 58%[79]; 83%[47] 
Belief that breast cancer is incurable 63%[57]  53%[79] 
Belief that cancer is curable 93%[61] ·· 
Belief that cancer is caused by evil spirits 60%[57] 40%[72] 
Belief that rituals and worshipping could cure 
cancer  
35%[57]  
Gender roles   
Competing priorities (e.g. housework or 
childcare) 
7%[60]; 7%[62]; 7%[74]; 
12%[49]; 77%[73] 
·· 
Embarrassment about the examination 6%[60] 7%[81]; 15%[63] 
Pre-treatment interval   
Fear of escalation 25%[87] ·· 
Fear that treatment would have a negative 
impact on their relationship 
21%[87] ·· 
Refusal of treatment due to emotional barriers 31%[44] ·· 
Access barriers   
2+h travel time to the hospital 19%[74]; 50%[61]; 69%[53] ·· 
4+h travel time to the hospital 43%[75] ·· 
Financial barriers   
Financial barriers 47%[44]; 75% [75]  ·· 
Reliance on family and friends to fund 
treatment costs 
61%[61]; 75%[75]  ·· 
·· refers to not applicable or data not available  
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Qualitative studies: Meta-ethnography 
Narrative summary data (third order) are presented below. Supporting illustrative participant quotes (first order 
data) are presented in Table 4. 
Traditional, complementary or alternative medicine (TCAM). Most studies reported that the use of TCAM 
lengthened the patient, diagnostic and pre-treatment intervals. In observed studies in Indonesia and in African 
countries, TCAM was typically sought prior to modern medicine in the patient interval,[29, 33, 36, 43, 50, 59] 
after diagnosis in the pre-treatment interval[38, 78] or both[58] highlighting that help-seeking and accessing 
healthcare is a non-linear process.  
In hypothetical and observed studies mostly conducted in African countries, it was common to believe that 
breast [11, 34, 36, 50, 59, 64, 68, 76, 78] and prostate[54] symptoms were caused by evil spirits, a spell, or 
witchcraft o  a e ig  ause e.g. a oil [50, 64, 68]. Beliefs about causality generally prompted participants to 
visit TCAM healers in the patient interval in observed studies with breast cancer patients in African 
countries.[29, 36, 48, 64, 76, 78] Due to causal beliefs, TCAM was seen as a logical option to resolve symptoms 
and treat the perceived underlying cause in the patient interval, and was strongly influenced by cultural norms 
around TCAM use in Indonesia[38, 52] and in African countries.[36, 50, 54, 66, 78] In hypothetical[68, 69] and 
observed[33, 43, 50] studies conducted in African countries and Indonesia, participants reported beliefs that 
traditional medicine could cure breast [33, 50, 68], nasopharyngeal[43] and cervical[69] cancer; whereas, 
Egyptian participants in a hypothetical breast cancer study tended to believe that traditional medicine could 
only cure non-cancer conditions such as coughs and colds.[86]  
Help-seeking from TCAM practitioners after diagnosis substantially lengthened the pre-treatment interval. In 
African countries and in Indonesia TCAM was commonly sought post-diagnosis in breast[29, 36, 50, 66, 78], and 
non-breast[38, 43] cancer patients. In these studies, use of TCAM in the pre-treatment interval was usually 
encouraged by friends/family due to perceived affordability,[29, 38, 43, 66, 78, 79] easier access[43, 79] and 
more trusted care[36, 38, 43, 50, 69] when compared to modern medicine. In observed studies with breast 
cancer patients conducted in African countries, TCAM was sought in the pre-treatment interval to avoid 
mastectomy, thereby preserving breasts to avoid social exclusion.[33, 50, 52, 78] In African breast cancer 
patients, biomedical cancer treatment was sought in the pre-treatment interval when symptoms did not resolve 
or worsened, typically at an advanced cancer stage.[33, 36, 50, 66]   
Gender effects. In observed studies with breast[29, 33, 76, 83] and oral[35] cancer patients, and hypothetical 
breast cancer studies[68, 79]conducted in African and Asian countries it was common for women to require 
permission from the family, usually their husband, prior to help-seeking in the patient interval[29, 33, 35, 68, 76, 
79, 83] and for husbands to make the final decision regarding treatment in the pre-treatment interval[76]. In 
observed breast cancer studies conducted in African and Asian countries, husbands were a key influence on 
either prompting help-seeking or refusing permission to seek medical help in the patient interval or treatment in 
the pre-treatment interval.[29, 33, 76, 78, 83] However, sometimes the hus a d s de isio  as o e idde   
the extended family.[33, 83] Breast examination by a male doctor was reported to be a key barrier in the patient 
and diagnostic intervals for Indian[59], Egyptian[65, 86] and Bangladeshi[83] women due to cultural beliefs 
about modesty.[59, 65, 83, 86]   
As primary caregivers, women in observed and hypothetical studies conducted in Indonesia and African 
countries reported prioritising family and work commitments over their personal health as barriers to help-
seeking for breast[36, 50, 58, 59, 66, 68] and non-breast[13, 38, 69] cancer symptoms in the patient interval. 
Medical help was sought in exceptional circumstances, typically if they were in pain and could not carry out 
domestic or childcare responsibilities.[58, 86] Limited financial resource meant that healthcare costs for women 
were often lower in priority, and when women in breast cancer studies eventually sought medical 
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help/treatment in all intervals, some described feeling guilty about using limited financial resources towards 
medical costs.[52, 64, 68]   
Cancer knowledge. Knowledge of breast[33, 36, 48, 65, 68, 86] and non-breast[43] cancer was generally 
obtained from social networks, although some participants in African[13, 34, 36, 64, 68] and Egyptian[86] breast 
cancer studies described the influence of cancer awareness campaigns. The point of diagnosis for some African 
breast[33, 36, 50] and Indonesian nasopharyngeal[43] cancer patients in observed studies was the first time 
they had heard of cancer.  
In observed and hypothetical studies conducted in Asian and African countries, breast,[83, 86] cervical,[13] 
prostate[54] and oral[35] cancer symptom knowledge was poor and mainly restricted to lumps as a cancer 
symptom.[36, 48, 68] In observed studies with breast cancer patients, misattribution of symptoms contributed 
to longer patient intervals.[11, 33, 35, 36, 41, 48, 50, 52, 58, 64, 76, 83] Lack of pain was a key barrier to help-
seeking in the patient interval in observed breast cancer studies conducted in African countries due to 
misattribution .[29, 33, 36, 41, 50, 58, 64, 76] Painless symptoms and/or symptoms that did not hinder daily 
functioning lengthened the patient interval in observed studies with African breast[33, 36, 41, 50, 66, 76] and 
Indonesian nasopharyngeal[43] cancer patients. Symptoms that persisted, changed or became painful motivated 
help-seeking in the patient interval in observed studies with breast[29, 33, 36, 41, 58, 65, 66] and cervical[13] 
cancer patients.   
Stigma. In hypothetical and observed studies conducted in Asian and African countries cancer was a source of 
shame and stigma[35, 48, 52, 54, 64] that influenced help-seeking across all intervals due to fear of social 
rejection and treatment, and presumed death after diagnosis.[29, 35, 54, 79, 83] In Indonesia and in African 
countries, cultural norms around cancer stigma and secrecy after breast[33, 48, 52, 64, 76] and prostate[54] 
cancer diagnosis meant that there was a lack of exposure to cancer a d egati e ill ess s o s su h as the 
bad disease [33, 36, 48, 86] were used. Cancer taboo was reinforced in hospital settings in African countries 
where health professio als efe ed to a e  as that disease  o  the sickness ,[64] and commonly withheld 
details of the diagnosis from the patient.[76] 
In observed and hypothetical studies conducted in Asian and African countries, breast[11, 29, 36, 50, 52, 59, 64, 
66, 68, 78, 83] and oral[35] cancer stigma stemmed from beliefs about the causes of cancer in general, where 
a e  as ai l  ie ed as a fo  of pu ish e t, out of o e s o t ol o  the patie ts  desti .[11, 29, 35, 36, 
50, 52, 59, 64, 66, 68, 78, 83] These beliefs lead to fear of disownment or mistreatment from family or the 
community in Asian and African countries.[48, 52, 59, 64-66, 79, 83] Participants in observed breast cancer 
studies reported that seeking social support after diagnosis in the pre-treatment interval was potentially risky 
due to stigma associated with cancer.[36, 76] In observed studies, strong religious beliefs facilitated acceptance 
of the consequences of their cancer in Indonesian nasopharyngeal cancer patients[43] and Ghanaian breast 
cancer patients[33] leading to refusal of cancer t eat e t, a epti g God s Will o  e t usti g God to u e the 
cancer without the need for biomedical treatment.[33, 35, 36, 43, 52, 76] 
Financial barriers. In hypothetical and observed studies, high medical and transportation costs were a major 
barrier in Asian and African studies across all intervals [11, 13, 29, 33, 34, 38, 43, 48, 50, 52, 54, 58, 59, 64-66, 68, 
76, 78, 83, 86], particularly for patients living in rural areas. Many participants did not have healthcare 
insurance, or insurance coverage was limited to certain treatments.[43, 52, 54, 64, 65] The pre-treatment 
interval in Asian and African studies was lengthened while breast[11, 29, 52, 58, 65, 83] and non-breast[13, 38, 
43] cancer patients in observed studies obtained the financial means to cover medical costs and/or transport, 
often using more affordable TCAMs. Patients in observed breast and non-breast cancer studies conducted in 
Indonesia and African countries[11, 29, 34, 58, 64, 76] relied on relatives, the community and the church for 
financial support for medical bills and transport costs which shortened the pre-treatment interval. 
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Social influences. Social networks – family, friends, the local community, elders, the church – were found to play 
a pivotal role in help-seeking at all intervals. In observed studies conducted in African and Asian countries, 
typically spouses, close relatives or church leaders were consulted upon discovery of a breast [33, 34, 36, 41, 58, 
64, 66] or non-breast[13, 35, 43] symptom. Symptom disclosure could lengthen or shorten the patient interval in 
observed studies with breast and non-breast cancer patients conducted in Asian and African countries 
depending on whether symptoms were attributed to cancer by friends and family[11, 13, 33, 35, 36, 41, 43, 58, 
64-66, 76, 78] and whether patients were encouraged to seek help from TCAM[11, 29, 33, 36, 58, 76, 78] or 
modern medicine.[11, 13, 35, 36, 41, 43, 58, 64, 66, 76] 
Beliefs about cancer.  Most studies assessing fearful and fatalistic cancer beliefs found that these lengthened all 
intervals. In observed and hypothetical studies conducted in Asian and African countries, breast,[29, 33, 36, 48, 
50, 52, 59, 68, 76, 79, 86]nasopharyngeal,[43] oral[35] and prostate[54] cancer was conceptualised as 
dangerous, painful and deadly. Negative beliefs were usually based on experiences of people within patie ts  
social network with a cancer diagnosis.[29, 33, 36, 48, 50, 52, 54, 65, 66, 76] There were few accounts of positive 
survival stories.[76] 
 For women in observed breast cancer studies conducted in African countries, the possibility of disfigurement 
lengthened the pre-treatment interval or led to treatment refusal.[33, 64, 66, 76, 78] In hypothetical and 
observed studies conducted in Indonesia[52] and in African countries,[33, 34, 64, 66, 78, 79] the removal of a 
o a s easts th ough aste to  as o side ed to di inish her sexual identity, self-worth, personal 
relationships and value in society. In hypothetical and observed breast cancer studies, women recounted 
examples of cancer diagnoses that resulted in divorce or social rejection.[48, 64, 66, 76, 79, 83] 
Modern medicine. One hypothetical breast cancer study conducted in Egypt reported positive views towards 
modern cancer treatment,[86] although few women in hypothetical and observed breast cancer studies 
reported knowledge about the benefits of early diagnosis for breast cancer.[29, 48, 64, 68, 86] In most observed 
and hypothetical studies conducted across African and Asian contexts, modern biomedical treatment for 
breast[33, 34, 36, 50, 52, 58, 59, 64, 83] and non-breast[43, 54, 69] cancer was generally perceived as expensive, 
invasive and ineffective, with harmful side effects that destroy the body and/or lead to disfigurement and 
shame. In some hypothetical and observed studies conducted in African countries, breast cancer surgery was 
believed to escalate cancer progression.[29, 52, 64, 68] 
Suspicion and mistrust of biomedical care in Asian and African countries lengthened the patient and pre-
treatment intervals in observed breast cancer studies, and prompted visits to TCAM practitioners.[11, 48, 50, 58, 
59, 65, 78] In hypothetical and observed studies conducted in African and Asian countries there was a perceived 
imbalance of power between doctors and patients, with reports of health professionals dominating discussions 
about treatment and lacking empathy.[43, 48, 50, 52, 58, 59, 65, 68, 69, 78] Breast [48, 52, 58, 59] and 
nasopharyngeal[43] cancer patients in observed studies were reluctant to question their diagnosis or ask 
questions in Asian and African countries. This power imbalance was most prominent in uninsured, lower 
income, less educated and rural patients, where some studies reported instances of mistreatment or suboptimal 
treatment.[11, 43, 48, 52, 69] In observed studies with breast[11, 48, 52] and nasopharyngeal[43] cancer 
patients, some low-income uninsured patients who were eligible for government assistance to cover healthcare 
costs sometimes described refusing the financial support due to fear of differential treatment by medically 





Table 4. Supporting quotes (first order data) from meta-ethnography 
Theme 
Sub-theme 
Example Quotations  
Patient interval  
Knowledge of cancer  
Symptom detection "After work, I came back home and while eating my second spoon, suddenly, as we 
say, an ant bit me in my breast. I stood up and removed my clothes. And 
automatically I saw a lump which I had never noticed before." (breast cancer, 
observed, Mali[11]) 
Self-examination 
behaviour/ source of 
symptom knowledge 
"Based on the education for frequent checks of the breast for cancer lumps, I 
developed the routine checks daily. It was during one of those checks for lumps that 
I ide tified the lu p i  y east the e y fi st o th I had y e opause." 
(breast cancer, observed, Ghana[34]) 
Symptom knowledge 
restricted to lumps  
Lump—the only one known—there could be other signs but lump is all that is 
known.  reast cancer, hypothetical and observed, Kenya[48]) 
Pain as a motivator for 
help-seeking 
I a e ith y siste . “he told e she had a lu p o  he  east a out t o yea s 
back. We were not worried that much because it was painless. But, starting last 
year, the lump become painful and we took her to [a clinic]."  (breast cancer, 
observed, Ethiopia[41]) 
Change in symptoms as 
a motivator for help-
seeking 
About 2 years back, I found a small hard lump over my left breast, but since it was 
small and I had no pain, I was not that much concerned about it. But it kept getting 
igge  a d igge ...  (breast cancer, observed, Ethiopia [41]) 
Lack of knowledge of 
cancer as a disease 
I had a solutely o idea hat east a e  as o  a y k o ledge a out the 
disease and symptoms before my diagnoses. I was totally ignorant about what was 
going on in my breast. Therefore, I did not take any action earlier." (breast cancer, 
observed, Ghana[36]) 
Low knowledge of the 
aetiology of disease 
"I have never seen someone with this disease before in my home. How would I have 
known that it was a bad disease, cancer? I just thought it would go away" (breast 
cancer, observed, Ghana[33]) 
Knowledge of cancer 
obtains from social 
networks 
This disease is very dangerous; I have seen my relatives and my neighbor who had 




They come and tell us in the church, before I know that there is something like 
that [ east a e ] to he k the easts.  (breast cancer, observed, Ghana[64]) 







Use of TCAM due to 
beliefs about causality 
I had a prophecy at church some months ago that a family witch (evil spirit) has 
bought breast cancer for me; just to destroy and kill me. I got delivered spiritually 
though. Hence, when it manifested physically as a lump in the breast, I took the 
spiritual route; I went for prayers. I deemed it as not a hospital disease; I ignored 
hospitals for more than a year  east a e , observed, Ghana[36]) 
Cease TCAM and seek 
medical help when 
TCAM was considered 
ineffective 
They [men] go first to the traditional healer because he or she is versed with the 
traditio al t eat e t. If it does t o k, the  they go to the hospital.  p ostate 





diagnosed with cancer 
Maybe if a girl is known to have breast cancer, one may be divorced if she is 
married. If a girl gets cancer and one of her breasts is removed obviously that one 
ill e eje ted. O e ti e…a o a  had a e . The hus a d s fa ily did ot 
a t he …They diso ned her.  east a e , hypothetical, Kenya[79]) 
 
Cancer fatalism For us cancer means death has arrived  p ostate a e , hypothetical, 
Cameroon[54])  
Cancer fatalism When I hear the word cancer, I see death, I see a growth that leads to death  
(breast cancer, hypothetical and observed, Kenya[48]) 
Belief that their cancer 
was caused by a spell 
"He said y hus a d fought ith so e ody a d that, that pe so  [ ast a spell]… 
so the spell was meant for my husband but it did not get him so it attacked me" 
(breast cancer, observed, Ghana[64]) 
 
Belief that their cancer 
was a spiritual attack 
"My cancer is a spiritual attack, it is caused by witches and wizards, I [knew] it 
would happen. I was told that cancer arrow would be fashioned" (breast cancer, 
observed, Nigeria[76]) 
 
Social influences  
Lay symptom disclosure 
facilitated symptom 
interpretation and 
promoted medical help 
seeking 
"After a year, I went to [Eastern Ethiopia] where my biggest child lives. I told him 
that I had a lump on my breast. I think he heard about breast cancer. He 
immediately took me to nearby clinic.  east a e , observed, Ethiopia[41]) 
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Lay symptom disclosure 
facilitated 
misattribution 
"I showed it to many people, some said maybe you are approaching menopause, 
others said that it is nothing. After I saw two lumps appearing, without any pain 
but which were growing, I showed it to a pharmacist who called [name]. He told 
me it is a furuncle but taking antibiotics will prevent it from growing. I talked to my 
husband who said that I have nothing and that I talk too much." (breast cancer, 
observed, Mali[11])  
Seek symptom advice 
from religious leader 
I told my pastor and then he recommended Dr. X  east a e , observed, 
Ghana[64]) 
Husband prompted help 
seeking 
I first told my husband. My husband told me to go to the hospital immediately.  
(cervical cancer, observed, Uganda[13])  
Husband encouraged 
help seeking from 
TCAM 
I told y hus a d. He told e that he has o o ey a d that I should ask God fo  
help and see a traditional healer. His younger brother also said someone has put a 
spell on me." (breast cancer, observed, Mali[11]) 
Gender roles  
women prioritise family 
and work commitments 
over their personal 
health 
"Women have no time for themselves. You take care of the children; you take care 
of the husbands, the shamba [vegetable garden], and everything, even the 
[extended] family... In fact, there are few of us who take care of ourselves such as 
going for a walk or going for aerobics. If you take a holiday, people will look at you. 
You are seen as somebody who is not okay. It is not in our culture." (breast cancer, 
hypothetical, Kenya[68])  
Women typically suffer 
in silence 
A o a  does t k o  ho  to e si kly o  pity he self...If the hus a d falls si k, 
he exaggerates his illness, but the wife bears her sickness in silence and hides it.  
(breast cancer hypothetical, Kenya[68]) 
Male health prioritised  A o a  a  ea  it if it is a se ious disease ut a a  says No I a ot, I ust 
see a do to  ui kly .  east a e , hypothetical, Egypt[86])  
Wo e s health 
relegated to second 
place 
Our society is male dominant, and here women are often neglected. It is the same 
for government and everyone else. This is one of the reasons why the awareness of 
this kind of disease [breast cancer] is almost non-existent.  east a e , 
observed, Bangladesh[83]) 
Diagnostic interval  
Difficulty navigating the 
healthcare system 
"I e t a ou d looki g fo  do to s, as I did t k o  anything about this subject. 
Nor did I know what doctor to go to; should he be a surgeon or a medical doctor? 
All these things I knew very late." (breast cancer, observed, Egypt[65]) 
Power imbalance 
between doctor and 
patient  
We listen to what the doctor says because the doctor knows, he was trained in 
a y thi gs. You do t k o  a ythi g. “o if he tells you to do so ethi g, you ha e 





examination from a 
male doctor 
"It is embarrassing to have a breast examination by a male doctor.  east a e , 
hypothetical, Egypt[86]) 
System barriers It took three years for me to know that it was cancer because they took it [sample] 
to Bla ty e. I  the fi st yea , it got lost. They took a othe  sa ple. It got lost agai . 
During the third time, that was when they diagnosed cancer of the breast.  east 
cancer, observed, Malawi[58]) 
Pre-treatment interval  
Reliance on traditional, 
alternative or 
complementary 
medicine (TCAM)  
 
Belief that TCAM can 
cure cancer 
"There is a strongly held belief among men in Bamenda that diseases like prostate 
cancer need to be treated as a spiritual illness and traditional medicine is better 
suited for such." (prostate cancer, hypothetical, Cameroon[54]) 
Use of TCAM due to 
fear of surgery 
I was really afraid of surgery, it was not wrong to try another treatment such as 
herbal medicine and another method of traditional treatment which were more 
comfortable for me  east a e , observed, Indonesia[52]) 
 
Use of TCAM as a cure 
for cancer and for 
perceived affordability 
I do t k o  the a es of all the he s; k o ledge is i he ited f o  p e ious 
ge e atio s, y g a dpa e ts […] I  usi g alte ati e t eat e t e ause I just 




inform families of 
diagnosis rather than 
the patient 
"It was my sister and her husband who were informed and they did not want to tell 
e e ause I te d to o e ea t.  (breast cancer, observed, Mali, observed, 
Mali[11]) 
 
Fear of cancer stems 
from social networks 
I felt it was the end of the world, because I had not seen anyone who recovered 
from it.  east a e , observed, Uganda[66]) 
 
Beliefs about cancer 
being contagious 
"People say it is contagious, and some say not. They think that I should not make 
food for them. They are frightened of me. They fear me. I am frightened my 
children will get it. I feel as if I am a germ." (breast cancer, observed, Egypt[65]) 
32 
 
The need to re-focus 
the mind to cope with a 
diagnosis of cancer 
E e ythi g is f o  the i d; this is hat I al ays say. If you tu e you  i d, you 
ill e okay.  (breast cancer, observed, Ghana[34]) 
 
Religious beliefs to cure 
cancer 
This a e  is y desti y; I just ha e to e patie t, a ept y o ditio  a d t y to 
seek a t eat e t, ut o ly God a  heal  (breast cancer, observed, Indonesia[52]) 
 
The need to maintain a 
positive attitude to cure 
cancer 
"This cancer is painful, but I'm going to fight back. It is going to hurt me, but I am 
also going to fight back. I am not going to allow it to get over me. I decided to 
remain positive despite what has happened" (breast cancer, observed, Uganda 
[66]) 
 
Fear of modern 
biomedical treatment 
 
Belief that modern 
medicine was 
ineffective and invasive 
"I was told that cancer medicine kills everything – good and bad inside you. I 
decided to keep living and not kill myself with those dangerous medicines." (breast 
cancer, observed, Ghana[33]) 
e te al  a e s 
perceived as more 
t eata le tha  i te al  
cancers 
"The simplest form of cancer as far as I know is breast cancer. Someone who has 
colon cancer has lots of operations. When I had the operation, I felt that the 
operation recovered the person, and it was over in a certain period of time. Cancer 
of the lung very bad, cancer of the colon bad." (breast cancer, observed, Egypt[65]) 
 
Preference to die from 
cancer than undergo 
mastectomy 
A woman's glory is her breast, so what is your use if one of your breasts is not 





My husband even wanted a divorce because he said I had been maimed." (breast 
cancer, observed, Ghana[64]) 
 
Removal of breasts 
considered to diminish 
a o a s se ual 
identity 
"Some think that if you have no breast then your husband would not have 
something to hold; there are many places the man can play with; so one can still 







Suspicion about modern 
medicine 
"They say medicines given from hospital here [to the community] could be family 
planning pills given secretly, and many of them are not ready to do family planning. 
Others even say that [community outreach] is an organization for devil 
worshippers.  east a e , hypothetical, Kenya[79]) 
 
High financial cost of 
modern medicine 
"If you do t ha e the fi a ial po e , eithe  you o  you  hus a d, they do t 
care for you, even if you cry; but if they know you have money, they give you 
atte tio . That s hy I a  usi g t aditio al edi i e." (breast cancer, observed, 
Mali[11])  
Reluctance to use 
government assistance 
for medical bills due to 
fear of mistreatment 
I would like to pay no matter what, my son told me not to use BPJS they would 
treat us like less important  Nasopha geal a e , observed, Indonesia[43]) 
Access problems I was worried about transport [. . .] If it was near, I could have been coming 
sooner.  east a e , observed, Malawi[58]) 
Economic hardship  
High transportation 
costs 
We ely o  fa i g i  o de  to fi d o ey fo  t a spo t…[ e e e] aiti g u til 
e sell to a o to fi d money to use for transport to go.  east a e , observed, 
Malawi[58]) 
Did not accept 
treatment due to cost 
Immediately I went to the lab and came here, they immediately scheduled me for 
su ge y. I did t ha e o ey so I e t ho e a d e e  a e a k e ause I did t 
ha e o ey… I u  a ay e ause of the o ey.  east a e , observed, 
Ghana[64]) 
Prioritising educational 
bills over medical bills 
At the time I discovered this lump in my breast, my daughter had just been 
a epted i to [u i e sity] to study u si g… I did t o e [follo  up ith 
t eat e t] e ause I ould t ha e ee  a le to o k to p o ide [fi a ially] fo  
my child and I would have dest oyed he  life… so I a ted to he  to go e ause I 
knew that even if I had passed away, she would have entered the University.  
(breast cancer, observed, Ghana[64]) 
Social influences  
Husband refused 
permission to seek 
medical; family 
overrode decision 
"My husband was against mastectomy, but my mother and uncle prevailed upon 
me to have it. I obeyed my mother and uncle and had the mastectomy even though 
I thought just removing the lump would be okay since the breast looked normal." 




"A day to the operation, my husband decided not to allow the operation to come 
o . I as su se ue tly dis ha ged e e  though the do to  as t happy a out it. I 
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was taken to a[n] herbalist. In fact, I went through a lot." (breast cancer, observed, 
Ghana[33]) 
Accepting God s Will "A o di g to the i le i  Je e iah 3 : 7; the o d of God says that I shall e 
hole agai , I elie e that they ill ot ut it a d the lu p ill go". (breast 





This was the first comprehensive review of psychosocial barriers to medical help-seeking behaviour for cancer 
symptoms and access to healthcare in LMIC. Use of TCAM was a key barrier to prompt medical help-seeking in 
LMIC. Consulting TCAM was influenced by causal beliefs about symptoms, familial pressure to visit a traditional 
healer, ease of access, affordability, and a preference to avoid biomedical treatment. Biomedical treatment was 
perceived as invasive, disfiguring, ineffective and expensive, and in some contexts medically trained doctors 
were perceived as untrustworthy and corrupt. Fear, shame and stigma associated with cancer was a barrier to 
help-seeking that prompted refusal of treatment due to fear of social rejection. Women were seen as having 
particular high levels of challenges and barriers to prompt cancer help-seeking, such as needing permission from 
the husband or family to contact the medical system, their health being seen as lower value, and female-specific 
stigma around breast cancer. The cost of travel and healthcare appointments/treatment was a key barrier 
across all intervals. 
 
Consistent with previous narrative reviews and one meta-analysis conducted in HIC and/or LMIC contexts, low 
symptom knowledge,[14, 15, 89] misattribution of symptoms,[16, 19, 89] negative beliefs about cancer[14, 18, 
19] and fear of treatment[17, 90] were associated with longer patient intervals, suggesting these are universal 
barriers to cancer help-seeking. Findings from our meta-ethnography indicate that cancer is highly stigmatised in 
LMIC partly due to beliefs about causation and low knowledge of the disease, and impacts help-seeking across 
all intervals. One review of breast cancer studies in LMIC contexts found fair to moderate evidence that the use 
of TCAM healers lengthened the patient interval,[17] while our updated review covering all cancers found strong 
evidence that use of TCAM was prevalent and a key influence on help-seeking across all intervals. No review in 
HIC has reported use of alternative medicines, suggesting that TCAM use may be particularly important in LMIC.  
 
Due to the predominance of breast cancer studies and patient interval studies, we were unable to draw strong 
conclusions in relation to help-seeking in the diagnostic and pre-treatment intervals, or for non-breast tumours 
and male help-seeking. Additionally, some findings were presented descriptively meaning it was not possible to 
assess their influence on time to help-seeking. Heterogeneity among the quantitative studies precluded a formal 
meta-analysis[91] due to inconsistencies in help-seeking thresholds e.g., defi itio s of dela  a ged f o  t o 
weeks[40] to six months[41]) and the use of a wide range of psychosocial measures, many of which were 
unvalidated, increasing the difficulty of integrating findings. There were additional inconsistencies in the 
reporting of statistical results, for example not reporting non-significant findings and not providing full 
information needed to interpret statistical results. The quantitative study team met frequently to discuss each 
paper in detail and the dataset as a whole to agree on which variables could be analysed using meta-analytic 
techniques. Due to consistency of reporting and the high number of studies that assessed TCAM use, TCAM use 
was the only variable that could be analysed using meta-analytic techniques. It is a limitation of our review that 
other non-TCAM variables could not be summarised using meta-analytic techniques for comparison. Due to 
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small sample sizes, it was not possible to assess whether TCAM use varied as a function of region. There are 
methodological limitations associated with measuring observed and hypothetical help-seeking behaviour, with a 
possible intention-behaviour gap in hypothetical studies and recall bias in observed studies. We included both 
types of studies in our review to balance the limitations associated with each study design.   
 
Future research on cancer help-seeking behaviour in LMIC should consider using validated measures[7, 8] with 
reporting of all statistical results (significant or not) and use of odds ratios, to allow for summarisation across 
studies. Freely available and validated measures include the Cancer Awareness Measure,[92] the Awareness and 
Beliefs about Cancer Measure,[93] and the Cancer-Symptom Interval Measure.[94] Pilot testing should be 
conducted with a sample of potential participants to ensure cultural relevance of translated or new survey 
items. A number of studies in our review included limited assessment of TCAM, and further research is required 
to understand in depth the influences of TCAM on the patient interval.  
Lack of symptom knowledge and negative beliefs about cancer appear to be universal barriers to cancer help-
seeking behaviour, suggesting that elements of existing awareness campaigns (e.g. Be Clear on Cancer; 
https://www.cancerresearchuk.org/health-professional/awareness-and-prevention/be-clear-on-cancer) could 
potentially be adapted for LMICs. Cultural and context-specific barriers reflecting TCAM use and gender 
influences on medical help-seeking are key barriers in LMIC that would need to be addressed sensitively and in 
collaboration with local communities.  
CONCLUSION 
With rapidly rising cancer incidence in LMIC, efforts to improve early cancer diagnosis and treatment through 
system-level interventions and individual behavioural interventions are critical to reduce cancer mortality. 
Interventions must address major barriers to medical help-seeking for symptoms and decisions to access 
healthcare for diagnosis and treatment in LMIC by raising cancer awareness, modifying negative beliefs, and 
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